0001752724-21-215924.txt : 20211012
0001752724-21-215924.hdr.sgml : 20211012
20211012100333
ACCESSION NUMBER: 0001752724-21-215924
CONFORMED SUBMISSION TYPE: N-CEN
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20210731
FILED AS OF DATE: 20211012
DATE AS OF CHANGE: 20211012
EFFECTIVENESS DATE: 20211012
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: AB DISCOVERY GROWTH FUND, INC.
CENTRAL INDEX KEY: 0000019614
IRS NUMBER: 136021421
STATE OF INCORPORATION: NY
FISCAL YEAR END: 0731
FILING VALUES:
FORM TYPE: N-CEN
SEC ACT: 1940 Act
SEC FILE NUMBER: 811-00204
FILM NUMBER: 211317405
BUSINESS ADDRESS:
STREET 1: ALLIANCEBERNSTEIN LP
STREET 2: 1345 AVENUE OF THE AMERICAS
CITY: NEW YORK
STATE: NY
ZIP: 10105
BUSINESS PHONE: 2129691000
MAIL ADDRESS:
STREET 1: ALLIANCEBERNSTEIN LP
STREET 2: 1345 AVENUE OF THE AMERICAS
CITY: NEW YORK
STATE: NY
ZIP: 10105
FORMER COMPANY:
FORMER CONFORMED NAME: ALLIANCEBERNSTEIN DISCOVERY GROWTH FUND, INC.
DATE OF NAME CHANGE: 20121031
FORMER COMPANY:
FORMER CONFORMED NAME: ALLIANCEBERNSTEIN SMALL MID CAP GROWTH FUND
DATE OF NAME CHANGE: 20081103
FORMER COMPANY:
FORMER CONFORMED NAME: ALLIANCEBERNSTEIN MID CAP GROWTH FUND INC
DATE OF NAME CHANGE: 20030319
0000019614
S000010117
AB DISCOVERY GROWTH FUND, INC.
C000028067
Class A
CHCLX
C000028068
Class B
CHCBX
C000028069
Class C
CHCCX
C000028070
Advisor Class
CHCYX
C000028071
Class R
CHCRX
C000028072
Class K
CHCKX
C000028073
Class I
CHCIX
C000144785
Class Z
CHCZX
N-CEN
1
primary_doc.xml
X0404
N-CEN
LIVE
0000019614
XXXXXXXX
811-00204
false
false
false
N-1A
S000010117
C000028072
C000028067
C000028069
C000028071
C000028068
C000028070
C000144785
C000028073
AB DISCOVERY GROWTH FUND, INC.
811-00204
0000019614
549300I01DFK1EYZ2O55
ALLIANCEBERNSTEIN LP
1345 AVENUE OF THE AMERICAS
NEW YORK
10105
US-NY
US
212-969-1000
State Street Bank and Trust Company
1 Lincoln Street
Boston
02111
617-786-3000
Custody and Accounting Records
N
N
N-1A
1
Y
Jorge A. Bermudez
N/A
N
Garry L. Moody
N/A
N
Jeanette W. Loeb
N/A
N
Michael J. Downey
N/A
N
Onur Erzan
N/A
Y
Earl D. Weiner
N/A
N
Nancy P. Jacklin
N/A
N
Carol C. McMullen
N/A
N
Marshall C. Turner, Jr.
N/A
N
Vincent S. Noto
N/A
1345 Avenue of the Americas
New York
10105
XXXXXX
N
N
N
N
N
N
N
AllianceBernstein Investments, Inc.
8-30851
000014549
0000000000
Y
N
Ernst & Young LLP
42
00000000000000000000
N
N
N
N
N
N
N
AB DISCOVERY GROWTH FUND, INC.
S000010117
549300I01DFK1EYZ2O55
N
9
0
0
N/A
N
N
Y
N
N
State Street Bank and Trust Company
571474TGEMMWANRLN572
N
N
Revenue sharing split
427718122.05000000
1177118.00000000
Rule 22d-1 (17 CFR 270.22d-1)
Rule 12d1-1 (17 CFR 270.12d1-1)
Rule 32a-4 (17 CFR 270.32a-4)
Y
Y
N
N
AllianceBernstein L.P.
801-56720
000108477
0JK55UGWSWNF3X7KLQ85
N
AllianceBernstein Investor Services, Inc.
084-01187
0000000000
Y
N
N
Vertical Management Systems, Inc.
27-3275288
Tax ID
N
Standard & Poor's Financial Services LLC
549300U4VWNITEKO2881
N
PricingDirect Inc.
549300WIC0TOJ7N7GD54
N
Refinitiv US Holdings Inc.
549300NF240HXJO7N016
N
Bloomberg L.P.
549300B56MD0ZC402L06
N
IHS Markit Ltd.
549300HLPTRASHS0E726
GB
N
ICE Data Services, Inc.
13-3668779
Tax ID
N
N
The Hongkong and Shanghai Banking Corporation Limited
2HI3YI5320L3RW6NJ957
HK
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
Clearstream Banking S.A.
549300OL514RA0SXJJ44
LU
N
Y
Foreign securities depository - rule 17f-7 (17 CFR 270.17f-7)
State Street Bank and Trust Company (Edinburgh, GB, Branch)
571474TGEMMWANRLN572
GB
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
State Street Bank and Trust Company
571474TGEMMWANRLN572
N
N
Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1))
N
AllianceBernstein Investor Services, Inc.
0000000000
Y
N
N
AllianceBernstein L.P.
0JK55UGWSWNF3X7KLQ85
Y
N
N
Sanford C. Bernstein Limited
N/A
N/A
54930049G8WQ5OOUSD19
GB
0.00000000
Sanford C. Bernstein & Co., LLC
8-52942
000104474
549300I7JYZHT7D5CO04
0.00000000
Liquidnet, Inc.
8-52461
000103987
213800HSKBBO1GCVRG79
39651.97000000
Barclays Capital Inc.
8-41342
000019714
AC28XWWI3WIBK2824319
48801.31000000
Morgan Stanley & Co. LLC
8-15869
000008209
9R7GPTSO7KV3UQJZQ078
94887.99000000
Credit Suisse Securities (USA) LLC
8-422
000000816
1V8Y6QCX6YMJ2OELII46
77637.41000000
Goldman Sachs & Co. LLC
8-129
000000361
FOR8UP27PHTHYVLBNG30
260093.52000000
UBS Securities LLC
8-22651
000007654
T6FIZBDPKLYJKFCRVK44
37879.15000000
Citation Group Ltd.
8-43632
000028305
00000000000000000000
89478.11000000
Cowen and Company, LLC
8-22522
000007616
549300WR155U7DVMIW58
106924.47000000
J.P. Morgan Securities LLC
8-35008
000000079
ZBUT11V806EZRVTWT807
69564.97000000
Jefferies LLC
8-15074
000002347
58PU97L1C0WSRCWADL48
26915.87000000
958172.09000000
J.P. Morgan Securities LLC
8-35008
000000079
ZBUT11V806EZRVTWT807
34895157.00000000
Barclays Capital Inc.
8-41342
000019714
AC28XWWI3WIBK2824319
17987775.00000000
Credit Suisse Securities (USA) LLC
8-422
000000816
1V8Y6QCX6YMJ2OELII46
9857965.50000000
Goldman Sachs & Co. LLC
8-129
000000361
FOR8UP27PHTHYVLBNG30
89274389.00000000
BofA Securities, Inc.
8-69787
000283942
549300HN4UKV1E2R3U73
32942065.00000000
State Street Bank and Trust Company
N/A
N/A
571474TGEMMWANRLN572
2669598347.59000000
Morgan Stanley & Co. LLC
8-15869
000008209
9R7GPTSO7KV3UQJZQ078
62109274.75000000
2916664973.84000000
Y
3579623371.41230769
Committed
325000000.00000000
N
N
N
N
true
INTERNAL CONTROL RPT
2
NCEN_811-00204_2922580243.txt
Report of Independent Registered Public
Accounting Firm
To the Shareholders and Board of Directors of AB
Discovery Growth Fund, Inc.:
In planning and performing our audit of the
financial statements of AB Discovery Growth Fund,
Inc. (the "Fund") as of and for the year ended July
31, 2021, in accordance with the standards of the
Public Company Accounting Oversight Board
(United States), we considered the Fund's internal
control over financial reporting, including controls
over safeguarding securities, as a basis for
designing our auditing procedures for the purpose
of expressing our opinion on the financial
statements and to comply with the requirements of
Form N-CEN, but not for the purpose of expressing
an opinion on the effectiveness of the Fund's
internal control over financial reporting.
Accordingly, we express no such opinion.
The management of the Fund is responsible for
establishing and maintaining effective internal
control over financial reporting. In fulfilling this
responsibility, estimates and judgments by
management are required to assess the expected
benefits and related costs of controls. A company's
internal control over financial reporting is a process
designed to provide reasonable assurance regarding
the reliability of financial reporting and the
preparation of financial statements for external
purposes in accordance with U.S. generally
accepted accounting principles. A company's
internal control over financial reporting includes
those policies and procedures that (1) pertain to the
maintenance of records that, in reasonable detail,
accurately and fairly reflect the transactions and
dispositions of the assets of the company; (2)
provide reasonable assurance that transactions are
recorded as necessary to permit preparation of
financial statements in accordance with U.S.
generally accepted accounting principles, and that
receipts and expenditures of the company are being
made only in accordance with authorizations of
management and directors of the company; and (3)
provide reasonable assurance regarding prevention
or timely detection of unauthorized acquisition, use
or disposition of a company's assets that could have
a material effect on the financial statements.
Because of its inherent limitations, internal control
over financial reporting may not prevent or detect
misstatements. Also, projections of any evaluation
of effectiveness to future periods are subject to the
risk that controls may become inadequate because
of changes in conditions, or that the degree of
compliance with the policies or procedures may
deteriorate.
A deficiency in internal control over financial
reporting exists when the design or operation of a
control does not allow management or employees,
in the normal course of performing their assigned
functions, to prevent or detect misstatements on a
timely basis. A material weakness is a deficiency, or
a combination of deficiencies, in internal control
over financial reporting, such that there is a
reasonable possibility that a material misstatement
of the company's annual or interim financial
statements will not be prevented or detected on a
timely basis.
Our consideration of the Fund's internal control
over financial reporting was for the limited purpose
described in the first paragraph and would not
necessarily disclose all deficiencies in internal
control that might be material weaknesses under
standards established by the Public Company
Accounting Oversight Board (United States).
However, we noted no deficiencies in the Fund's
internal control over financial reporting and its
operation, including controls over safeguarding
securities that we consider to be a material
weakness as defined above as of July 31, 2021.
This report is intended solely for the information
and use of management and the Board of Directors
of AB Discovery Growth Fund, Inc. and the
Securities and Exchange Commission, and is not
intended to be and should not be used by anyone
other than these specified parties.
/s/ ERNST & YOUNG LLP
New York, New York
September 24, 2021